Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
about
Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitusInitiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Clinical significance of sCD163 and its possible role in asthma (Review).Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study.Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissueSwitch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.Connection between telomerase activity in PBMC and markers of inflammation and endothelial dysfunction in patients with metabolic syndrome.Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanicsLate Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver DiseaseImpact of age on markers of HIV-1 diseaseCD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage.Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaquesImmunometabolism in obese asthmatics: are we there yet?Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapyChanges in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infectionThe macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids.Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity.CD163 and inflammation: biological, diagnostic, and therapeutic aspects.Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.Effect of Pericardial Fat Volume and Density on Markers of Insulin Resistance and Inflammation in Patients With Human Immunodeficiency Virus Infection.Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass.The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes.Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus.Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.
P2860
Q33596529-9E8B4604-310F-4C20-AC73-381D0EBE6659Q33649200-3396068B-2674-45A7-B6B1-91DEE5D34F7FQ33674640-4B01251C-95FF-41F8-86EC-5299EB2C7DC8Q33825980-BB735084-1684-41DD-B615-BA29EC258C7CQ33831093-7AADE9F1-82D5-4308-8D81-C07360DF8165Q33934080-2B3D1E5C-6852-44F2-8428-BE88E5072BB6Q34256706-07FEADB0-9174-468E-ADED-61F0ADF7042CQ35122399-89D6637E-4E2F-41FF-BC55-4D89D93CC271Q35860942-1EB478D7-3A83-43AB-AFDA-31A4FD051AA2Q36001196-F43E5D54-BCB1-43C8-82A9-2D278C900E31Q36751382-33304488-5A94-4E21-80CF-0177D8B6596FQ36763762-5E95B118-0B91-4382-9350-14BA42960F48Q37196512-005A7A2F-8EED-4CBB-A4B8-D345CD4A9376Q37208031-35F1303E-F778-45B5-839E-D2FB6E66A29CQ37235370-440D9E5D-B456-4A11-B3F0-3AA0946AFD89Q37248840-ECEB6462-CA1B-4D37-94D9-4881A13B9561Q37305570-553C6FBF-4A84-4D03-B46E-2A52F587DBF8Q37351669-AAEACE3E-03D7-4C4F-A7CB-D45EEEBEB426Q37358244-2B4CF04C-C0EA-4F62-9218-F7E004BA658EQ37704756-580E5B13-9F15-4E92-B229-DB4B7B969A72Q38035395-FB239FF6-1966-4A41-9EB3-CFB57B44ECEDQ38177684-A1899DF2-2C6E-4282-AC02-AA5923BD3BE4Q40077741-5ACFCEDA-70A1-4D55-A47C-7C1CDA2BAAF0Q40374706-C8B7D33F-99BA-4ACC-B509-CE8C46EEADA4Q41219178-6946904A-5899-4590-B90D-1CFD32743C38Q47246931-E37C4A76-157F-4C6E-9678-B47DA5092710Q47426766-82D5C04F-6E4E-4AE6-942C-C219BAEAAEC1Q47896040-06EE678A-BA60-496B-A9F8-5E19E518F2B9Q49212062-0CADD8A6-C0BB-478F-A64E-702D685FC12BQ50456399-49F7E657-DD13-4812-A9D9-7C2135773037Q51280278-F8E49A3A-2DA8-4B18-B98C-85D14AB8AA63Q53691000-D4FB4B55-F9D1-4F3A-990E-31A128877CA6Q55367038-DD2119C9-97F1-403A-8946-55B86567039A
P2860
Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Relationship between monocyte/ ...... se and normal-weight subjects.
@en
type
label
Relationship between monocyte/ ...... se and normal-weight subjects.
@en
prefLabel
Relationship between monocyte/ ...... se and normal-weight subjects.
@en
P2093
P2860
P1476
Relationship between monocyte/ ...... se and normal-weight subjects.
@en
P2093
Hideo Makimura
Kenneth C Williams
Markella V Zanni
Steven K Grinspoon
Tricia H Burdo
P2860
P304
P356
10.1111/J.1365-2265.2011.04284.X
P577
2012-09-01T00:00:00Z